Tower Research Capital (TRC)’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6K | Sell |
8,492
-12,944
| -60% | -$46.6K | ﹤0.01% | 3385 |
|
|
2025
Q1 | $64.1K | Buy |
21,436
+17,819
| +493% | +$53.3K | ﹤0.01% | 2047 |
|
|
2024
Q4 | $12.1K | Sell |
3,617
-8,117
| -69% | -$27.2K | ﹤0.01% | 3649 |
|
|
2024
Q3 | $39.3K | Buy |
11,734
+2,252
| +24% | +$7.54K | ﹤0.01% | 2857 |
|
|
2024
Q2 | $31.4K | Buy |
9,482
+8,012
| +545% | +$26.5K | ﹤0.01% | 3457 |
|
|
2024
Q1 | $5.94K | Sell |
1,470
-28,870
| -95% | -$117K | ﹤0.01% | 4463 |
|
|
2023
Q4 | $92.5K | Buy |
30,340
+17,042
| +128% | +$52K | ﹤0.01% | 2706 |
|
|
2023
Q3 | $39.9K | Buy |
13,298
+7,552
| +131% | +$22.7K | ﹤0.01% | 2743 |
|
|
2023
Q2 | $21.5K | Buy |
5,746
+2,590
| +82% | +$9.69K | ﹤0.01% | 3304 |
|
|
2023
Q1 | $11K | Sell |
3,156
-17,888
| -85% | -$62.3K | ﹤0.01% | 4183 |
|
|
2022
Q4 | $101K | Buy |
21,044
+3,239
| +18% | +$15.5K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $102K | Sell |
17,805
-5,697
| -24% | -$32.6K | ﹤0.01% | 2547 |
|
|
2022
Q2 | $167K | Buy |
23,502
+22,203
| +1,709% | +$158K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $9K | Buy |
1,299
+46
| +4% | +$319 | ﹤0.01% | 4432 |
|
|
2021
Q4 | $11K | Sell |
1,253
-5,336
| -81% | -$46.8K | ﹤0.01% | 4384 |
|
|
2021
Q3 | $231K | Buy |
6,589
+4,908
| +292% | +$172K | 0.01% | 1681 |
|
|
2021
Q2 | $36K | Buy |
1,681
+952
| +131% | +$20.4K | ﹤0.01% | 3294 |
|
|
2021
Q1 | $45K | Buy |
729
+397
| +120% | +$24.5K | ﹤0.01% | 3208 |
|
|
2020
Q4 | $14K | Buy |
+332
| New | +$14K | ﹤0.01% | 4088 |
|